Gene Query: TMEM205

Dataset Description Geneva Score
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 72.15
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 31.96
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 31.91
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 28.88
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 27.35
Nutritional control of protein translation 27.01
CDK4/6 inhibitor resistance in prostate cancer 21.87
Silencing p300 in MCF7 cells to study expression and alternative splicing 21.75
TGF-β promotes genomic instability after loss of RUNX3 21.62
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 21.45
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 19.27
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 19.17
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 18.11
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 16.79
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 16.13
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 16.13
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 16.06
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 15.25
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 15.25
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 15.22
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 15.02
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 14.81
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 14.8
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 14.52
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 14.41
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 14.41
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 14.35
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 14.33
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 14.25
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 14.25
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 13.9
Patient-derived luminal breast cancer xenografts with progestins 13.9
RNA-seq of IL-4 stimulated human keratinocytes 13.83
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 13.63
KLF6-dependent transcription in renal cancer cells 13.57
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 13.08
The comparison of high-throughput single-cell RNA-seq methods 13.01
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 12.63
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 12.42
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 12.32
Rorc disruption in human FG pancreatic cancer cells 12.19
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 12.18
Effect of FGF13 depletion on the H460 cell line 12.1
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 12.02
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 11.72
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 11.51
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 11.41
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 11.3
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 11.3
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 11.21
Transcriptomic analysis of human tonsillar TFH subsets 11.19
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 11.17
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 11.17
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 11.1
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 10.94
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 10.53
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 10.5
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 10.44
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 10.41
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 9.99
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 9.91
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 9.91
Chromatin-informed inference of transcriptional programs in gynecologic cancers 9.84
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 9.84
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 9.84
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 9.84
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 9.74
Identification of HOXB13 target genes responsive to BET inhibitors 9.6
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 9.57
HNRNPL and its RNA Targets in Prostate Cancer 9.55
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 9.55
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 9.52
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 9.51
H1609088 Human RNA-Sequencing 9.46
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 9.37
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 9.35
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 9.33
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 9.23
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 9.21
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 9.08
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 9.05
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 9.0
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 8.99
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 8.96
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 8.94
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 8.79
Total RNA sequencing of WT intestinal orgaonids. 8.71
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 8.65
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 8.6
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 8.58
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 8.58
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 8.53
The role of FAM46C in myeloma cells 8.47
The role of FAM46C in myeloma cells [sequencing] 8.47
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 8.37
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 8.33
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 8.31
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 8.31
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 8.28
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 8.28
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 8.27
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 8.25
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 8.08
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 7.96
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 7.94
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 7.94
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 7.94
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 7.88
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 7.88
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 7.84
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 7.83
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 7.83
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 7.74
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 7.74
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 7.71
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 7.66
Impact of dieldrin on transcription in Jurkat T cells 7.55
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 7.51
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 7.51
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 7.49
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 7.47
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 7.32
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 7.25
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 7.24
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 7.22
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 7.22
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 7.18
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 7.15
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 7.03
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 7.02
RNA sequencing of BT142 and TS603 cell lines 7.02
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 7.02
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 7.02
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 6.99
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 6.99
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 6.95
RNA-seq of shEZH2 cells 6.95
Effect of mitochondria deficiency on senescence-associated gene expression 6.91
Evaluating pre-clinical models for studying NASH driven HCC. 6.87
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 6.86
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 6.8
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 6.8
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 6.76
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 6.73
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 6.63
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 6.59
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 6.59
Tracking of dCas9-methyltransferase footprints 6.57
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 6.56
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 6.55
RNA-seq differential expression studies: more sequence, or more replication? 6.49
ARS2 is a general suppressor of pervasive transcription [RNAseq] 6.48
Illumina Total RNA-seq in HeLa 6.42
scRNASeq analysis of cycling cardiomyocytes 6.41
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 6.34
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 6.34
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 6.34
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 6.33
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 6.3
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 6.29
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 6.24
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 6.24
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 6.24
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 6.22
Human Treg IL-12 stimulation 6.22
RNA editing in nascent RNA affects pre-mRNA splicing 6.21
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 6.19
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 6.19
N6-methyladenine DNA Modification in Glioblastoma 6.18
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 6.18
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 6.17
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 6.17
PTHrP overexpression in MCF7 cells 6.14
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 6.12
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 6.11
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 6.11
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 6.07
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 6.02
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 5.99
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 5.95
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 5.95
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 5.94
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 5.93
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 5.93
Integrating single-cell transcriptomic data across different conditions, technologies, and species 5.92
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 5.9
Characterization of parental and rociletinib-resistant derived H1975 cell lines 5.89
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 5.88
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 5.84
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 5.83
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 5.82
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 5.81
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 5.8
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 5.73
Overexpression of NFIB and YBX1 in MCF-7 cells 5.72
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 5.7
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 5.69
T47D RNA-seq and ChrRNA-seq data 5.69
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 5.68
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 5.64
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 5.64
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 5.63
RNA-seq analysis of the human fetal kidney. 5.61
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 5.57
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 5.57
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 5.46
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 5.43
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 5.41
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 5.41
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 5.4
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 5.36
Gene expression profile in breast cancer cell lines using RNA sequencing 5.34
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 5.33
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 5.31
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 5.29
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 5.29
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 5.26
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 5.24
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 5.21
Gene expression signatures of innate lymphoid cells from human blood 5.18
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 5.18
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 5.15
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 5.15
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 5.15
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 5.15
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 5.13
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 5.11
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 5.11
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 5.1
Overexpression and knockdown experiment for circCSNK1G3 5.1
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 5.1
Lipid degradation promotes prostate cancer cell survival 5.07
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 4.98
RNA-sequencing of human liver tissue 4.97
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 4.97
A transcriptome dataset revealing the molecular features of breast cancer stem cells 4.91
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 4.88
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 4.86
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 4.78
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 4.78
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 4.76
Paxillin regulates genomic networks in prostate cancer [PC3] 4.74
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 4.73
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 4.73
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 4.73
Non-coding regions are the main source of tumor-specific antigens [human] 4.7
Non-coding regions are the main source of tumor-specific antigens 4.7
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 4.69
Global analysis of enhancer targets: Mosaic-seq 4.65
ARID1A and ARID1B loss in HCT116 cells 4.59
Targeting MTHFD2 in Acute Myeloid Leukemia 4.58
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 4.51
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 4.51
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 4.47
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 4.45
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 4.45
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 4.43
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 4.41
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 4.37
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  4.36
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 4.27
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 4.24
HNRNPM-regulated splicing dependencies in prostate cancer 4.24
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 4.21
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 4.18
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 4.16
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 4.15
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 4.14
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 4.14
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 4.1
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 4.08
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 4.05
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 4.01
The transcriptome effect of overexpressing EZH2 in MCF7 4.0
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 3.98
MRTF activates TEAD-YAP target gene expression 3.94
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 3.93
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 3.89
Genome-wide Analysis of Chromatin Interactions in Human Cells 3.88
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 3.88
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 3.87
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 3.86
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 3.84
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 3.83
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 3.83
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 3.82
Redifferentiation of expanded human islet β cells by inhibition of ARX 3.81
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 3.8
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 3.78
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 3.78
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 3.78
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 3.78
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 3.76
Gene expression changes due to PARP knockdown in human cells 3.75
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 3.74
Transcriptional dependencies in diffuse intrinsic pontine glioma 3.73
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 3.71
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 3.7
Gene expression analysis of human hepatocellular cancers 3.64
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 3.62
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 3.62
EWSR1 influences alternative splicing through direct and indirect mechanisms 3.62
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 3.61
Hepatocyte maturation 3.6
RNAseq of cell lines with knocked in ESR1 mutations 3.5
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 3.5
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 3.42
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 3.4
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 3.38
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 3.32
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 3.32
Functional Haploid Human Oocytes Generated from Polar Body Genomes 3.3
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 3.3
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 3.25
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 3.25
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 3.24
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 3.2
Mutational landscape of splicing genes and functional consequences across 33 cancer types 3.19
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 3.16
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 3.15
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 3.11
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 3.1
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 3.09
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 3.09
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 3.08
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 3.08
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 3.08
Investigate A2M treatment on human prostate cancer and mouse liver 3.06
Investigate A2M treatment on human prostate cancer xenograft in mice 3.06
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 3.06
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 3.05
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 3.01
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 3.01
Tpl-2 and MEK small molecule inhibitors 2.99
Tpl-2 small molecule project 2.99
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 2.97
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 2.96
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 2.94
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 2.86
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 2.83
miRNAs affected by antagomiR-17 treatment 2.8
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 2.8
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 2.79
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 2.78
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 2.77
Microprocessor mediates transcription termination in long noncoding microRNA genes 2.75
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 2.75
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 2.72
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 2.66
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 2.66
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 2.66
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 2.65
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 2.6
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 2.6
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 2.6
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 2.59
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 2.58
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 2.57
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 2.57
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 2.49
A single cell reference map for human blood and tissue T cell activation 2.48
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 2.44
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 2.4
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 2.39
Iron response of HepG2 cells 2.35
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 2.33
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 2.3
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 2.3
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 2.3
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 2.3
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 2.27
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 2.26
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 2.22
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 2.22
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 2.22
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 2.21
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 2.21
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 2.21
RNA sequencing of human mammary epithelial cells 2.18
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 2.15
Expression profiling of MCF-7 cells with treatment of TCDD 2.05
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 2.05
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 2.04
Fusion discovery in breast cancer cell line 2.01
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 2.0
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 2.0
Downregulation of LATS kinases alters p53 to promote cell migration 1.96
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 1.95
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 1.85
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 1.84
TT-Seq captures the human transient transcriptome 1.83
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 1.8
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 1.79
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 1.78
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 1.78
Transciptomic profiling of human fetal lung samples 1.76
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 1.73
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 1.65
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 1.64
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 1.63
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 1.63
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 1.63
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 1.58
RNA-Seq of Breast and Ovarian Cancer Cell Lines 1.56
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 1.54
Gene expression analysis of breast cancer cell-lines 1.53
Gene expression and genome-wide location analysis of breast cancer cell-lines 1.53
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 1.52
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 1.5
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 1.47
Identification of long noncoding RNAs regulated by p53 1.45
Expression charcaterization of an internal protocol developed to differentiate RPE cells 1.42
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 1.41
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.4
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 1.37
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 1.36
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 1.33
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 1.33
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 1.32
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 1.28
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 1.27
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 1.26
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 1.26
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 1.22
Copper Regulation of HIF-1 Transcription Activity 1.22
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 1.21
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 1.21
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 1.19
Positively selected enhancer elements endow tumor cells with metastatic competence 1.19
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 1.16
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 1.14
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 1.12
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 1.12
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 1.12
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 1.09
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 1.08
Single-cell analysis of human kidney organoids 1.07
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 1.07
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 1.04
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 1.04
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 1.03
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 1.03
m6A-dependent regulation of messenger RNA stability 1.01
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 1.01
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 1.0
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 0.99
RNA-Seq of PRMT1 overexpression ECA109 cells 0.99
Interaction between mitoNEET and NAF-1 in cancer cells 0.97
Hepatic transcriptome of pediatric hepatoblastoma. 0.96
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.94
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 0.92
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.84
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 0.83
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.81
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 0.81
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 0.81
Expression analysis of the TAF1 syndrome 0.79
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 0.76
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 0.73
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 0.73
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 0.73
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.72
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 0.68
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.66
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 0.64
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.59
MCF-7 as a model for functional analysis of breast cancer risk variants 0.57
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 0.56
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 0.56
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.52
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.51
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.51
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.38
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 0.36
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.35
Enhancer activation during EGF response 0.35
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.34
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 0.34
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.32
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 0.28
Regulatory network controlling tumor-promoting inflammation in human cancers 0.28
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.26
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 0.26
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.25
Specific molecular signatures underlie response to decitabine in CMML 0.25
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.24
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 0.19
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 0.19
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.19
RNAseq of Breast cancer PDX samples 0.19
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 0.13
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 0.1
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 0.07
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 0.07
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 0.07
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.07
Transcriptomic analysis of human macrophages in 3D 0.04
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.03
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.01
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation